1 A metastatic histiocytic sarcoma case with primary involvement of the tonsil

2 Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters

3 Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer?

4 Initial Experience of Pembrolizumab Therapy in Japanese Patients With Metastatic Urothelial Cancer.

5 Quantification of Economic Impact of Drug Wastage in Oral Oncology Medications: Comparison of 3 Methods Using Palbociclib and Ribociclib in Advanced or Metastatic Breast Cancer.

6 Afatinib for the treatment of metastatic non-small cell lung cancer

7 Afatinib for the treatment of metastatic non-small cell lung cancer

8 Afatinib for the treatment of metastatic non-small cell lung cancer

9 Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma

10 Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience

11 A Case Presentation of a Patient with Microsatellite Instability and BRAF Mutant Metastatic Colon Cancer and Bibliography Update

12 Multifocal Metastatic Breast Carcinoma to the Thyroid Gland Histologically Mimicking C Cell Lesions

13 Stauffer’s Syndrome in Patient with Metastatic Prostate Cancer

14 Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM).

15 A treatment landscape in evolution: new strategies, guidelines, and therapeutic advances for metastatic pancreatic adenocarcinoma

16 Utilization pattern and service settings of palliative care for patients with metastatic non-small-cell lung cancer.

17 Essential Concepts for the Management of Metastatic Spine Disease: What the Surgeon Should Know and Practice.

18 Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen.

19 TUBB4B Downregulation Is Critical for Increasing Migration of Metastatic Colon Cancer Cells.

20 Correction to: Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability (Nature Communications, (2018), 9, 1, (5005), 10.1038/s41467-018-07538-7)

21 Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology

22 Predicting Overall Survival in Patients with Metastatic Rectal Cancer: a Machine Learning Approach.

23 Can curcumin along with chemotherapeutic drug and lipid provide an effective treatment of metastatic colon cancer and alter multidrug resistance?

24 Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer.

25 Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment

26 Noninfectious causes of diffuse pulmonary infiltrations in chronic renal failure: metastatic pulmonary calsification.

27 Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour.

28 Management of patients with metastatic prostate cancer (mPC) in a rural part of North Norway with a scattered population: does living near the department of oncology translate into a different pattern of care and survival?

29 Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in Japan.

30 Utilizing Molecular Network Information via Graph Convolutional Neural Networks to Predict Metastatic Event in Breast Cancer.

31 Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial.

32 Targeting prostate cancer cell proliferation, stemness and metastatic potential using derived phytochemicals.

33 Prevalence of BRAF gene mutation in samples of primary and metastatic colorectal cancer: A meta-analysis.

34 Dramatic response to Laetrile and cannabidiol (CBD)oil in a patient with metastatic low grade serous ovarian carcinoma

35 Tumor-to-Tumor Metastasis: Metastatic Invasive Lobular Carcinoma of the Breast within Adenocarcinoma of the Lung.

36 The PI3K/AKT/mTOR and CDK4/6 pathways in endocrine resistant HR+/HER2- metastatic breast cancer: Biological mechanisms and new treatments

37 Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.

38 Outcome and feasibility of palliative chemotherapy in very elderly patients with metastatic breast cancer.

39 Greater Mindfulness Associated With Lower Pain, Fatigue, and Psychological Distress in Women with Metastatic Breast Cancer.

40 Brainwashed by extracellular vesicles: the role of extracellular vesicles in primary and metastatic brain tumour microenvironment

41 The clinical significance of metastatic breast carcinoma to intramammary lymph node.

42 Guideline Discordance and Patient Cost Responsibility in Medicare Beneficiaries With Metastatic Breast Cancer.

43 Bevacizumab Demonstrates Prolonged Disease Stabilization in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma: A Case Series and Review of the Literature

44 Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial.

45 Poly(N,N-diethyl acrylamide)/functionalized graphene quantum dots hydrogels loaded with doxorubicin as a nano-drug carrier for metastatic lung cancer in mice

46 CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database.

47 Unusual cutaneous metastatic carcinoma.

48 CT-based radiomics for prediction of histologic subtype and metastatic disease in primary malignant lung neoplasms.

49 Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years.

50 Reply to “Letter to the Editor” intent of surgery of the primary tumor in metastatic breast cancer remains palliative

51 Complex management decisions in a woman with concurrent primary hyperparathyroidism and metastatic papillary thyroid carcinoma, both presenting during pregnancy.

52 Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer

53 Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer.

54 Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model.

55 Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice.

56 The Metastatic Early Prognostic (MEP) score.

57 Does small volume metastatic lymph node disease affect long-term prognosis in early cervical cancer?

58 Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression.

59 Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancer

60 Synchronicity of genetic variants between primary sites and metastatic lymph nodes, and prognostic impact in nodal metastatic lung adenocarcinoma

61 Trifluridine/Tipiracil for the Treatment of Metastatic Gastric Cancer.

62 [Clinical application of convolutional neural network in pathological diagnosis of metastatic lymph nodes of gastric cancer].

63 Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-values.

64 The discordance pattern of molecular sub-types between primary and metastatic sites in Chinese breast cancer patients.

65 Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.

66 Re: Safety and Outcomes of New Generation Hormone-Therapy in Elderly Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Patients in the Real World

67 Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival.

68 Relaxins enhance growth of spontaneous murine breast cancers as well as metastatic colonization of the brain.

69 "I'd Want to Know, Because a Year's Not a Long Time to Prepare for a Death": Role of Prognostic Information in Shared Decision Making among Women with Metastatic Breast Cancer.

70 Prognostic factors associated with locoronal relapses, metastatic relapses, and death among women with breast cancer. Population-based cohort study

71 PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy

72 Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.

73 Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer.

74 A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

75 Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?

76 "The day you lose your hope is the day you start to die": Quality of life measured by young women with metastatic breast cancer.

77 The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].

78 The suppressive effect of dabrafenib, a therapeutic agent for metastatic melanoma, in IgE-mediated allergic inflammation.

79 [Characteristics of CMR Appearance in a Case of Cardiac Metastatic Melanoma].

80 Utility of Claudin-4 versus BerEP4 and B72.3 in pleural fluids with metastatic lung adenocarcinoma.

81 Threshold for interpretation of p16 immunostaining in fine-needle aspirate specimens of metastatic oropharyngeal squamous cell carcinoma.

82 Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study.

83 High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.

84 Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: An Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitors.

85 Metronomic palliative chemotherapy in locally advanced, recurrent and metastatic head-and-neck cancer: A single-arm, retrospective study of a regional cancer center of North India (Asia)

86 Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index

87 First-line pazopanib in intermediate- and poor-risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial

88 Intrahepatic metastatic nodules of hepatocellular carcinoma detected at Lipiodol-CT: imaging-pathologic correlation

89 Validity of 3-Tesla diffusion-weighted magnetic resonance imaging for distinction of reactive and metastatic lymph nodes in head-and-neck carcinoma

90 Metronomic palliative chemotherapy in locally advanced, recurrent and metastatic head-and-neck cancer: A single-arm, retrospective study of a regional cancer center of North India (Asia)

91 A metastatic histiocytic sarcoma case with primary involvement of the tonsil

92 Nursing care study: metastatic carcinoma of the breast

93 Nursing care study: metastatic carcinoma of the breast.

94 Validity of 3-Tesla diffusion-weighted magnetic resonance imaging for distinction of reactive and metastatic lymph nodes in head-and-neck carcinoma

95 Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer Patients

96 What is a clinically meaningful survival benefit in refractory metastatic colorectal cancer?

97 Evaluation of the HER2 and Hormone Receptor Status in Metastatic Breast Cancer Using Cell Blocks: A Multi-Institutional Study

98 checkpoint molecule pd-1-assisted cd8+ t lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

99 a case of an epithelioid hemangioendothelioma arising from the innominate vein mimicking cervical metastatic lymphadenopathy

100 metastatic prolactinoma: case report with immunohistochemical assessment for p53 and ki-67 antigens prolactinoma metastático: relato de caso com avaliação imuno-histoquímica para os antígenos p53 e ki-67

101 seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma

Keyword Connections

Journals

Research Groups

Bibliographies